ReviewACS medicinal chemistry letters2025
Evolving Landscape: Accounts of Academic-Industrial Collaborations in Chemistry Technology.
Review in ACS medicinal chemistry letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancing Drug Discovery through Academia-Industry Collaborations: Lessons from Merck Discovery Chemistry Partnerships.ACS central science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Academic-industrial collaborations in the pharmaceutical industry have led to advances in novel science and pipeline goals. These partnerships find success by leveraging the resources and expertise of the industrial sector with the creativity and depth of knowledge of academic researchers. Here, we discuss case studies of several past and present academic-industrial collaborations from a chemistry technology group and their evolution from operating under funding-driven models to more reciprocal exchanges of effort and information. Effective partnerships depend on the careful selection of the right collaborators and projects, and they require clear communication, alignment of interests, and patience throughout the phases of a collaboration. Research areas of high interest for academic collaborations are discussed, such as advancements in synthetic methodology and drug discovery platforms such as DNA-encoded libraries and PROTACS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.